XRCC6 and neoplasm: In addition, acetylation of nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2), decreased Tam-induced apoptosis and/or increased Ku70-Bax interaction may also contribute to the tumor promoter role of SIRT3 [7].